Thursday will be heavy with U.S. macroeconomic data releases, which could potentially shift investors’ focus from geopolitical issues to economic momentum.
The highlight will be the final reading of U.S. GDP for the third quarter of 2025, which according to the Bloomberg consensus is expected to show growth of 4.3% (previously: 3.8%). Private consumption played a particularly important role in Q3, so a continuation of this trend and a potentially stronger-than-expected reading could significantly push market expectations for the Fed toward less willingness to continue cutting interest rates.
Alongside GDP, reports on PCE inflation for October and November will also be released, including the Fed’s preferred Core PCE measure. The picture will be complemented by weekly jobless claims, which have been in a strong downward trend for weeks, thereby easing concerns about the U.S. labor market.
For the Euro Area the key release will be the minutes from the latest ECB meeting.
All times CET; filtered by: US, UK, Eurozone, Germany. Source: xStation5
Daily summary: Wall Street, precious metals and EURUSD surge📈Bitcoin under pressure
Oil slips below $64 after EIA data📌NATGAS drops despite favorable inventories report
Gold gains 1%, silver surges 3% 📈Precious metals near record levels again
NATGAS surges 11% amid US arctic frost reaching record level since 2022 📈
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
